Navigation Links
David Ebersman Joins Ironwood Board of Directors
Date:9/14/2009

CAMBRIDGE, Mass., Sept. 14 /PRNewswire/ -- Ironwood Pharmaceuticals, Inc. today announced that David Ebersman has joined the Company's Board of Directors. Mr. Ebersman is the chief financial officer of Facebook. He served at Genentech from 1994-2009 in a number of senior positions, including executive vice president and chief financial officer, senior vice president of product operations, vice president of product development, and project team leader for Avastin((R)), Genentech's breakthrough cancer therapy.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081006/NEM080ALOGO )

"We are thrilled to have David join our board. He is owner-oriented, exceptionally strategic, and committed to fostering an environment with a high degree of integrity. He also brings broad industry experience that will enrich our Board deliberations," said Peter Hecht, CEO of Ironwood.

"I share the Ironwood team's passion for delivering important new medicines to patients," said Mr. Ebersman. "I am excited to contribute to Ironwood's efforts to build a great and enduring business."

Mr. Ebersman has an A.B. in economics and international relations from Brown University and is a fellow in the Henry Crown Fellowship Program.

About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals (www.ironwoodpharma.com) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, the Company's first-in-class compound, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood has raised $306 million in private equity financing and is located in Cambridge, Massachusetts.

    Contact:
    Susan Brady
    Corporate Communications
    617.621.8304
    sbrady@ironwoodpharma.com


'/>"/>
SOURCE Ironwood Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. David Duncan Has a Prescription for American Health Care
2. Delcath Systems, Inc. Appoints David McDonald Chief Financial Officer
3. David Blumenthal and Aneesh Chopra Give Keynote Addresses at AMIAs Conference on Anticipating and Addressing Unintended Consequences of HIT and Policy
4. Allied Worlds David Bell to Present as Keynote Speaker at 2009 Entrepreneurial Insurance Symposium
5. Pro Quarterback David Garrard Aims to Score Big For Crohns Disease During the 2009 Football Season
6. Health Expert Dr. David Friedman Reveals Which Sweeteners Are Best
7. Dr. David Okrongly Appointed CEO of Quanterix Corporation
8. Jackson & Coker Names David Booher Vice President of Emergency Medicine Recruitment
9. Phoenix Cardiovascular Surgeon, David J. Caparrelli, M.D. Becomes Member of the Society for Vascular Surgery
10. Re-Envision Your Look: Dr. David Whiteman Suggests Breast Revision Surgery as Solution for Women Dissatisfied with Prior Procedures
11. Huntsville, Alabama Plastic Surgeon David L. Durst, MD Comments on Silicone Breast Implants after Nearly 3 Years on the Open Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... , ... Cheerag D. Upadhyaya , M.D., M.Sc., FAANS has been appointed ... part of Saint Luke’s Health System . Dr. Upadhyaya has served in the ... FAANS joins Stanley P. Fisher, M.D., who has served as medical co-director ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... Substance Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted Response to the ... of Health Care Services, will facilitate the development of a hub and spoke ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... scholarship awards to be awarded annually to and divided between two full-time university ... bringing awareness to Amazonian plant medicine. To apply for the scholarship, students are ...
(Date:7/24/2017)... ... July 24, 2017 , ... Axiad IDS , a leading provider of ... with WALLIX to expand its solution to help government contractors more quickly ... number of ways to address the authentication requirements within NIST SP800-171, but no ...
(Date:7/24/2017)... ... ... A CDC study shows that, although people are taking more steps to protect themselves from ... least one case of sunburn within the past year. It’s common and people have been ... However, only recently have people become conscientious of the risks that accompany sunburns. , The ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... CARLSBAD, Calif. , July 10, 2017  The ... in Boston, MA at the ... unequaled value and unparalleled access to global decision makers ... to draw 800+ life science leaders during two impactful ... Boston, and provides delegates with additional networking opportunities with ...
(Date:7/5/2017)... , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company focused ... that it has received approval from the Israel Securities Authority ... Exchange (TASE). Oramed common stock will commence trading on the ... on the current market capitalization of the Company, it is ...
(Date:6/30/2017)... 30, 2017 In vitro diagnostics market firm ... May, at least ten diagnostic companies have successfully completed ... offerings and a loan facility.  The size of these ... million.  Kalorama Information provides a monthly IVD Market ... Knowledge Center. ...
Breaking Medicine Technology: